---

title: Fc receptor binding proteins
abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
url: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PALL&S1=08815246&OS=08815246&RS=08815246
owner: Syntonix Pharmaceuticals, Inc.
number: 08815246
owner_city: Waltham
owner_country: US
publication_date: 20120914
---
